Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 17, 2021 - Issue
Submit an article Journal homepage
156
Views
3
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study

Masaomi Iyo1 Department of Psychiatry, Graduate School of Medicine, Chiba University, Chiba, JapanORCID Iconhttps://orcid.org/0000-0002-5384-857XView further author information
ORCID Icon,
Jun Ishigooka2 Institute of CNS Pharmacology, Tokyo, JapanView further author information
,
Masatoshi Nakamura3 Department of Data Science, Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-6100-5417View further author information
ORCID Icon,
Reiko Sakaguchi4 Department of Clinical Research, Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, JapanView further author information
,
Keisuke Okamoto5 Department of Clinical Operation, Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, JapanView further author information
,
Yongcai Mao6 Division of Data Science, Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USAView further author information
,
Joyce Tsai7 Division of Clinical Research, Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USAView further author information
,
Alison Fitzgerald8 Division of Clinical Operations, Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USAView further author information
,
Kentaro Takai9 Medical Affairs, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6105-4502View further author information
ORCID Icon &
Teruhiko Higuchi10 Japan Depression Center, Tokyo, Japan;11 National Center of Neurology and Psychiatry, Tokyo, JapanView further author information
 show all
Pages 2683-2695 | Published online: 16 Aug 2021

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Itaru Miura, Kei Watabe, Reiko Sakaguchi, Keisuke Okamoto & Hidenori Maruyama. (2022) Effectiveness of Lurasidone 80 mg in Patients with Schizophrenia: Results of an Open-Label, 12-Week Extension Study. Neuropsychiatric Disease and Treatment 18, pages 2627-2637.
Read now

Articles from other publishers (2)

María Elena Gamboa-Arancibia, Nelson Caro, Alexander Gamboa, Javier Octavio Morales, Jorge Enrique González Casanova, Diana Marcela Rojas Gómez & Sebastián Miranda-Rojas. (2023) Improving Lurasidone Hydrochloride’s Solubility and Stability by Higher-Order Complex Formation with Hydroxypropyl-β-cyclodextrin. Pharmaceutics 15:1, pages 232.
Crossref
A.V. Goryunov. (2021) Using Lurasidone in the treatment of mental illness in childhood. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121:11, pages 77.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.